Xylo Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
18
Xylo Bio General Information
Description
Developer of a psychedelic therapeutic platform designed to rewire neural circuits and restore brain function. The company offers novel, non-hallucinogenic, rapid-acting medicines for psychiatric and neurological disorders, enabling doctors to optimize treatments and transform care for patients with neurological and psychiatric conditions.
Contact Information
Website
www.xylo.bioCorporate Office
- 3415 Colorado Avenue
- Boulder, CO 80303
- United States
Corporate Office
- 3415 Colorado Avenue
- Boulder, CO 80303
- United States
Xylo Bio Timeline
Xylo Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 16-Oct-2025 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 25-Feb-2025 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 20-Aug-2024 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 19-Oct-2022 | $5M | $5.81M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 13-Aug-2021 | $811K | $811K | Completed | Stealth |
Xylo Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 3,174,648 | $0.000100 | $0.21 | $0.21 | 1x | $0.21 | 7.1% | |
| Seed-1 | 238,117 | $0.000100 | $0.2 | $0.2 | 1x | $0.2 | 0.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Xylo Bio Comparisons
Industry
Financing
Details
Xylo Bio Competitors (3)
One of Xylo Bio’s 3 competitors is Delix Therapeutics, a Venture Capital-Backed company based in Concord, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Delix Therapeutics | Venture Capital-Backed | Concord, MA | ||||
| Gilgamesh Pharma | Venture Capital-Backed | New York, NY | ||||
| Seaport Therapeutics | Venture Capital-Backed | Boston, MA |
Xylo Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Xylo Bio Patents
Xylo Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026908666-A0 | Compounds | Pending | 16-Oct-2026 | ||
| AU-2026902068-A0 | Compounds | Pending | 12-Mar-2026 | ||
| AU-2026902069-A0 | Compounds | Pending | 12-Mar-2026 | ||
| AU-2025900198-A0 | Compounds | Pending | 24-Jan-2025 | ||
| AU-2024904301-A0 | Compounds | Pending | 24-Dec-2024 |
Xylo Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Xylo Bio Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endless Frontier Labs | Accelerator/Incubator | Minority | ||
| One Mind | Accelerator/Incubator | Minority | ||
| Calm Ventures | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| M8 Ventures | Venture Capital | Minority |
Xylo Bio FAQs
-
When was Xylo Bio founded?
Xylo Bio was founded in 2021.
-
Where is Xylo Bio headquartered?
Xylo Bio is headquartered in Boulder, CO.
-
What is the size of Xylo Bio?
Xylo Bio has 33 total employees.
-
What industry is Xylo Bio in?
Xylo Bio’s primary industry is Drug Discovery.
-
Is Xylo Bio a private or public company?
Xylo Bio is a Private company.
-
What is Xylo Bio’s current revenue?
The current revenue for Xylo Bio is .
-
How much funding has Xylo Bio raised over time?
Xylo Bio has raised $13.8M.
-
Who are Xylo Bio’s investors?
Endless Frontier Labs, One Mind, Calm Ventures, Gaingels, and M8 Ventures are 5 of 18 investors who have invested in Xylo Bio.
-
Who are Xylo Bio’s competitors?
Delix Therapeutics, Gilgamesh Pharma, and Seaport Therapeutics are competitors of Xylo Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
